The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrufin Plc Regulatory News (TRU)

Share Price Information for Trufin Plc (TRU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 68.50
Bid: 68.00
Ask: 69.00
Change: 2.50 (3.76%)
Spread: 1.00 (1.471%)
Open: 68.00
High: 69.00
Low: 65.50
Prev. Close: 66.50
TRU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Satago signs commercial agreement with Lloyds

29 Jul 2022 07:00

RNS Number : 1584U
TruFin PLC
29 July 2022
 

29 July 2022

TruFin plc("TruFin" or the "Company")

 

 Satago Financial Solutions Limited ("Satago") announces the signing of the commercial agreement with Lloyds Bank plc ("Lloyds Banking Group" or the "Bank").

 

TruFin is pleased to announce that further to the Company's statement on 9 March 2022, Satago and Lloyds Banking Group have entered into a five-year commercial agreement for the Bank to license Satago's software platform for use by the Bank's Single Invoice Finance and Whole of Book Invoice Factoring customers. 

Satago's platform gives the Bank a new digitised proposition with which to further support UK businesses. Satago will receive a recurring fee for each Bank customer which utilises its platform, plus one-off implementation fees. Satago expects the software platform to be made available to the Bank's customers during Q4 2022.

This landmark contract, coupled with its growing pipeline of commercial partners, ensures Satago is well positioned to roll out its best-in-class platform - benefiting thousands of Single Invoice Finance and Whole of Book Invoice Factoring customers - in the years ahead.

Additionally, TruFin has today completed a further £2 million investment in Satago, as contemplated at the time of TruFin's recent fundraising announced on 22 March 2022. For the purposes of this investment, the valuation of Satago is the same pre-money valuation that Lloyds Banking Group participated at for their £5 million investment, as announced on 9 March 2022. Following this transaction, TruFin holds approximately 67% of Satago.

The signing of the commercial agreement constitutes a related party transaction under the AIM Rules for Companies (the "AIM Rules"), by virtue of Lloyds Banking Group being a substantial shareholder, as defined in the AIM Rules, of Satago, a subsidiary of the Company. The directors of TruFin consider, having consulted with the Company's nominated adviser, Liberum Capital Limited, that the terms of the transaction are fair and reasonable insofar as shareholders of the Company are concerned. The Company believes that the commercial terms are in line with market norms.

The Company confirms that it continues to trade in line with market expectations.

Sinead McHale, Chief Executive Officer of Satago, commented:

"The signing of this commercial agreement further solidifies our position as the best-in-class provider of innovative working capital solutions, I am immensely proud of our work to deliver a newly constructed Invoice Finance solution for Lloyds Banking Group. 

By working collaboratively with the Bank, together we will deliver a solution that democratises working capital solutions for SMEs all over the UK, regardless of size or sector."

Ben Stephenson, Managing Director and Head of Specialist Client Solutions, Lloyds Bank Commercial Banking said:

"This partnership demonstrates our commitment to helping businesses to optimise their working capital in order to recover, diversify, and grow. By partnering with Satago, we are enhancing the choices and speed at which SMEs can access finance solutions which is fundamental to our purpose of helping Britain prosper."

James van den Bergh, Chief Executive Officer of TruFin, commented:

"This commercial agreement with Lloyds Banking Group represents a transformational event for Satago. Combined with the strong pipeline of additional customers, the agreement has the scope to deliver significant value for TruFin and its shareholders."

The information contained within this Announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No.596/2014 as amended by The Market Abuse (Amendment) (EU Exit) Regulations 2019. By the publication of this Announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain. The person responsible for arranging for the release of this Announcement on behalf of the Company is Annie Styler.

 

For further information, please contact:

TruFin plcJames van den Bergh, Chief Executive OfficerKam Bansil, Investor Relations

0203 743 134007779 229508

Liberum Capital Limited (Nominated Adviser and Corporate broker)Chris ClarkeEdward Thomas

0203 100 2000

TruFin plc is the holding company of an operating group comprising four growth-focused technology businesses operating in niche markets: early payment provision, invoice finance, IFA finance and mobile games publishing. The Company was admitted to AIM in February 2018 and trades under the ticker symbol: TRU. More information is available on the Company website: www.TruFin.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBLGDRRDDDGDI
Date   Source Headline
12th Apr 20247:01 amRNSBlock Admission Application
12th Apr 20247:00 amRNSGrant of share awards under LTIP
2nd Apr 20247:00 amRNSAppointment of Director to the Board of Playstack
26th Mar 20247:01 amRNSSale of Interact platform
25th Mar 20247:00 amRNSSatago signs contract with Bank of Ireland Finance
19th Mar 20247:00 amRNSNotice of Results and Investor Presentation
18th Mar 20247:00 amRNSPlaystack announces over 1m units sold for Balatro
12th Mar 202411:07 amRNSHolding(s) in Company
22nd Feb 20247:00 amRNSPlaystack releases its fastest selling game
8th Feb 20247:00 amRNSTrading Update
4th Jan 20247:00 amRNSTrading Update
20th Dec 20239:40 amRNSHolding(s) in Company
14th Dec 20237:00 amRNSAppointment of INED to the Board of Oxygen
21st Nov 20237:00 amRNSPlaystack enters into LoI for sale of Interact
9th Nov 20237:00 amRNSOxygen Finance acquisition of bidstats.uk
18th Oct 20234:19 pmRNSHolding(s) in Company
5th Oct 20237:00 amRNSSale of Majority Holding in Vertus
29th Sep 20237:00 amRNSHalf-year Report
28th Sep 202312:07 pmRNSResult of AGM
14th Sep 20238:00 amRNSPlaystack releases award-winning game - AK-xolotl
29th Aug 20236:19 pmRNSNotice of AGM
21st Aug 20237:00 amRNSNon-Binding Offer for Vertus
28th Jul 20237:00 amRNSGrant of Share Awards under LTIP
18th Jul 20238:59 amRNSHolding(s) in Company
18th Jul 20238:58 amRNSHolding(s) in Company
18th Jul 20238:55 amRNSHolding(s) in Company
10th Jul 202312:03 pmRNSResult of GM and Result of Placing and Open Offer
23rd Jun 20237:00 amRNSResult of Placing and Notice of General Meeting
22nd Jun 20234:45 pmRNSProposed Placing and Open Offer
18th May 20233:04 pmRNSHolding(s) in Company
26th Apr 20237:00 amRNSOxygen Finance secures six Early Payment contracts
15th Mar 20237:00 amRNSFinal Results for the year ended 31 December 2022
28th Feb 20235:43 pmRNSHolding(s) in Company
23rd Jan 20237:00 amRNSStatement re Satago
20th Jan 20237:00 amRNSStatement regarding Satago and Trading Update
22nd Dec 20227:00 amRNSRejected Indicative Offer for Oxygen
15th Nov 20227:00 amRNSOxygen surpasses £1b in early payment provision
3rd Nov 20227:00 amRNSPlaystack releases new console game
20th Oct 20227:00 amRNSSatago signs agreement with Sage
10th Oct 20227:00 amRNSNotice of Capital Markets Day
30th Sep 20227:00 amRNSPDMR Notification
20th Sep 20227:00 amRNSInterim Results
12th Sep 20227:00 amRNSNotice of Capital Markets Day
25th Aug 20229:37 amRNSHolding(s) in Company
29th Jul 20229:00 amRNSPrice Monitoring Extension
29th Jul 20227:00 amRNSSatago signs commercial agreement with Lloyds
1st Jul 20227:00 amRNSHolding(s) in Company
9th Jun 20227:00 amRNSSatago partnership with Sage and Lloyds
7th Jun 202211:19 amRNSResult of AGM
6th Jun 20227:00 amRNSStatement re Playstack

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.